Current Report Filing (8-k)
February 26 2015 - 09:57AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 25, 2015
AMARANTUS BIOSCIENCE HOLDINGS, INC.
(Exact name of registrant as specified in
its charter)
Nevada |
333-148922 |
26-0690857 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
IRS Employer
Identification No.) |
655 Montgomery Street
Suite 900
San Francisco, CA |
94111 |
(Address of Principal Executive Offices) |
(Zip Code) |
(408) 737-2734
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 |
Other Events
On February 25, 2015, a Stipulation
of Dismissal with Prejudice in connection with Reginicin, Inc. v. Lonza Walkersville, Inc. et al Case No. 1:13-cv-3596 was filed
in United States District Court for the District of New Jersey pursuant to the Settlement Agreement dated February 23, 2015 by
and among Amarantus Bioscience Holdings, Inc., Lonza Group, Ltd., Lonza America, Inc. and Lonza Walkersville, Inc. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
|
AMARANTUS BIOSCIENCE HOLDINGS, INC. |
|
|
|
|
Date: February 26, 2015 |
By: |
/s/ Gerald E. Commissiong |
|
|
|
Name: Gerald E. Commissiong |
|
|
Title: Chief Executive Officer |
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Mar 2023 to Mar 2024